Want to join the conversation?
Vamil Divan of Credit Suisse asks about biosimilars, on Enbrel, what's the impact of biosimilars on 2016 results. $PFE President Geno Germano answers by saying that the first biosimilar for Etanercept has been approved in Europe. The overall expectation is that there will be some modest impact in 2016 and will have a strong business in Europe.
$TXMD flying high.. anyone here to catch..?
$CMG crashing. There seems to be nothing good to read about this company.
Impressed with $AMZN’s latest grocery ambitions. The new Amazon Go convenience store, is an absolute game changer.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$